Delivery Order SPE2DB24D1201-SPE2DB24FJBHM

Award Date 9/6/24
Potential Completion Date 9/9/24
Potential Value $36K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Epinephrine 0.3 mg auto-injectors. The delivery order, valued at $17,018.72, has a firm fixed-price contract type and an ultimate completion date of September 5, 2024. AmerisourceBergen, through its Corporate Office division, has been awarded this delivery order as a part of a larger Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,608.52 firm fixed price contract is for the supply of 4,564,491,963 units of Epinephrine 0.3 mg auto-injectors, with a completion date of May 6, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,378.21 firm fixed-price contract is for the delivery of epinephrine 0.3 mg auto-injectors, with a completion date of January 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
The Department of Defense's Defense Logistics Agency awarded a firm-fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the federal government. The $2,857.37 contract is for the delivery of Epinephrine 0.3 mg auto-injectors by September 6, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Epinephrine 0.3 mg auto-injection devices. The $1,531.20 firm-fixed-price contract has a completion date of September 20, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, for delivering a range of medical commodities to...
This is a delivery order award by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,555.68 firm fixed price contract is for the supply of 4560315340 Epinephrine 0.3 mg auto-injectors. This award is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support...
This federal contract award, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, provides for the delivery of 4,565,004,091 units of the Epinephrine 0.3 mg Auto-Injector, a critical medical supply, over the period ending on June 27, 2024. The $1,433.60 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and DLA, under which the company supplies a wide...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $9,992.83 firm fixed-price contract is for the supply of Epinephrine 0.3 mg auto-injectors, with an ultimate completion date of August 2, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including the DLA Troop Support Medical ($999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,539.17 firm fixed-price contract is for the procurement of 4,567,296,440 units of epinephrine 0.3 mg auto-injectors, with a performance period running through February 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The $2,067.08 firm fixed price award is for the supply of 4,565,215,508 units of Epinephrine 0.3 mg auto-injectors. The contract has an ultimate completion date of July 22, 2024. Amerisourcebergen, through its Corporate Office division, has been a significant provider of...
  • SPE2DB24D1201
    Indefinite Delivery Contract
  • SPE2DB24D1201-SPE2DB24FJBHM
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $36,171.46 firm fixed-price contract is for the supply of Epinephrine 0.3 mg auto-injectors. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of pharmaceutical and medical commodities from Amerisourcebergen to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is scheduled for completion by September 9, 2024. As a major pharmaceutical distributor, Amerisourcebergen leverages its extensive supply chain to provide critical medications, supplies, and equipment to various government agencies and healthcare programs.

Generated 12/6/24, 9:25 AM